
There have been sporadic cases Hemophagocytic Lymphohistiocytosis, associated with Cytomegalovirus Infection infection, suggesting that CMV may cause clinically significant disease beyond mononucleosis in immunocompetent individuals.
There have been sporadic cases Hemophagocytic Lymphohistiocytosis, associated with Cytomegalovirus Infection infection, suggesting that CMV may cause clinically significant disease beyond mononucleosis in immunocompetent individuals.
Experts discuss the bacteria’s transmission in the community setting, how to reduce disease and economic burdens, and ways to improve quality of life for patients.
Escalating usage and more drug choices are putting more people at risk.
This approach can help with clinical outcomes and mortality, but resistance is not as well defined.
The prevalence of this disease in this patient population is much higher than in the general public.
Ongoing education and proven outcomes need to aid this form of testing.
Our editor-in-chief writes on the role caregivers play in informing the public on the perks of a more vaccinated population.
Infectious diseases are emerging at an alarmingly rapid pace, faster than any other time in human history.